Artículo
Impact of COVID-19 on liver disease: From the experimental to the clinic perspective.
Autor/es | Gato, Sheila
Lucena-Valera, Ana Muñoz Hernández, Rocío Sousa, Jose Manuel Romero Gómez, Manuel Ampuero Herrojo, Javier |
Departamento | Universidad de Sevilla. Departamento de Fisiología Médica y Biofísica Universidad de Sevilla. Departamento de Medicina |
Fecha de publicación | 2021 |
Fecha de depósito | 2023-11-24 |
Publicado en |
|
Resumen | Coronavirus disease 2019 (COVID-19) has caused a global pandemic unprecedented in over a century. Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a predominantly respiratory infection, various ... Coronavirus disease 2019 (COVID-19) has caused a global pandemic unprecedented in over a century. Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a predominantly respiratory infection, various degrees of liver function abnormalities have been reported. Pre-existing liver disease in patients with SARS-CoV-2 infection has not been comprehensively evaluated in most studies, but it can critically compromise survival and trigger hepatic decompensation. The collapse of the healthcare services has negatively impacted the diagnosis, monitoring, and treatment of liver diseases in non-COVID-19 patients. In this review, we aim to discuss the impact of COVID-19 on liver disease from the experimental to the clinic perspective. Gato S, Lucena-Valera A, Muñoz-Hernández R, Sousa JM, Romero-Gómez M, Ampuero J. Impact of COVID-19 on liver disease: From the experimental to the clinic perspective. World J Virol 2021; 10(6): 301-311 [PMID: 34909404 DOI: 10.5501/wjv.v10.i6.301] |
Cita | Gato, S., Lucena-Valera, A., Muñoz Hernández, R., Sousa, J.M., Romero Gómez, M. y Ampuero Herrojo, J. (2021). Impact of COVID-19 on liver disease: From the experimental to the clinic perspective.. World journal of virology, 10 (6), 301-311. https://doi.org/10.5501/wjv.v10.i6.301. |